Sai Life Sciences profit and loss

Latest FY26

Revenue: ₹2,192cr+29.4% on FY25
EBITDA: ₹631cr+55.6% on FY25
Net profit: ₹349cr+105.1% on FY25
EPS: ₹16.63+88.3% on FY25

₹ crore except per share

Tap a line for its trend	Last 12Mto Jun 2026	FY26Mar 2026	FY25Mar 2025

Expenses
	2,250	2,192	1,695
	42.8	49.1	36.8
	2,293	2,242	1,731
	655	578	461
	−80.1	−7.2	5.0
	702	683	549
	34.5	39.2	76.2
	175	167	139
	315	307	274
	1,802	1,767	1,504
	658	631	406
	483	464	267
Profit
	491	474	228
	−8.0	−8.0	0.0
	483	466	228
	94.0	88.4	33.8
	27.6	28.9	23.7
	122	117	57.6
	362	349	170
	362	349	170
	−2.7	−20.8	1.2
	359	328	171
Per share
	₹17.17	₹16.63	₹8.83
	₹16.93	₹16.43	₹8.61
Other comprehensive income — detail
	−2.7	−20.8	1.2
	1.7	1.5	0.5
	0.4	0.4	0.1
	−7.7	−31.7	1.0
	−3.7	−9.8	0.2
Per share — as-filed variants
	₹17.17	₹16.63	₹8.83
	₹16.93	₹16.43	₹8.61
Derived — gross profit (revenue − materials − purchases − Δ inventories)
	1,676	1,622	1,229
	74.5%	74.0%	72.5%
Adjusted (ex-exceptional items) — derived
	491	474	228
	−8.0	−8.0	0.0
	368	355	170
	₹17.45	₹16.92	₹8.83

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

SAILIFE₹1,495.70

Sai Life Sciences Ltd.

· Pharma & Health

Annual Quarterly₹ CrorePeersSYNGENE DIVISLAB PPLPHARMA NH NEULANDLAB NATCOPHARM LALPATHLAB COHANCEMcap ₹31,676 Cr

View

In ₹ Crore except Per Share 12 Months Ending	FY25 31/03/2025	FY26 31/03/2026	Last 12M 30/06/2026
Revenue from Operations	1,694.6	2,192.5	2,250.4
Other Income	36.8	49.1	42.8
Total Income	1,731.3	2,241.6	2,293.1
Expenses
+ Cost of Materials Consumed	460.8	578.1	654.8
+ Changes in Inventories	5.0	-7.2	-80.1
+ Employee Benefit Expense	549.1	683.1	702.3
+ Finance Costs	76.2	39.2	34.5
+ Depreciation & Amortisation	138.6	166.9	175.1
+ Other Expenses	274.0	307.4	315.1
Total Expenses	1,503.6	1,767.4	1,801.7
EBITDA	405.7	631.2	658.2
EBIT	267.1	464.3	483.2
Profit
PBT before Exceptional Items	227.7	474.2	491.4
+ Exceptional Items	0.0	-8.0	-8.0
Pretax Income	227.7	466.2	483.4
+ Current Tax	33.8	88.4	94.0
+ Deferred Tax	23.7	28.9	27.6
Tax Expense	57.6	117.3	121.7
Net Income	170.1	348.9	361.7
+ Net Income — Continuing Ops	170.1	348.9	361.7
+ Other Comprehensive Income	1.2	-20.8	-2.7
Total Comprehensive Income	171.3	328.1	359.0
Per Share
Basic EPS	8.83	16.63	17.17
Diluted EPS	8.61	16.43	16.93
Other Comprehensive Income — detail
+ Other Comprehensive Income	1.2	-20.8	-2.7
+ Items NOT to be Reclassified to P&L	0.5	1.5	1.7
+ Tax on Items NOT to be Reclassified	0.1	0.4	0.4
+ Items to be Reclassified to P&L	1.0	-31.7	-7.7
+ Tax on Items to be Reclassified	0.2	-9.8	-3.7
Per Share — as-filed variants
Basic EPS — Continuing Operations	8.83	16.63	17.17
Diluted EPS — Continuing Operations	8.61	16.43	16.93
Derived — Gross Profit (Revenue − Materials − Purchases − Δ Inventories)
Gross Profit	1,228.8	1,621.6	1,675.7
Gross Margin %	72.51	73.96	74.46
Adjusted (ex-Exceptional Items) — derived
Pretax Income (Adjusted, as filed)	227.7	474.2	491.4
− Exceptional Items (reconciliation)	0.0	-8.0	-8.0
Net Income Adj (tax-effected)	170.1	354.9	367.7
EPS Adj	8.83	16.92	17.45
Other Filed Concepts — mapped but not yet placed in the schedule
Face Value	1.00	1.00	1.00
Paid Up Equity Capital	20.8	21.2	21.2

As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.